lomustine has been researched along with Benign Mastocytoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, M | 1 |
| Tsai, X | 1 |
| Bennett, P | 1 |
| Malone, EK | 1 |
| Rassnick, KM | 1 |
| Wakshlag, JJ | 1 |
| Russell, DS | 1 |
| Al-Sarraf, R | 1 |
| Ruslander, DM | 1 |
| Johnson, CS | 1 |
| Trump, DL | 1 |
2 trials available for lomustine and Benign Mastocytoma
| Article | Year |
|---|---|
Combination CCNU and vinblastine chemotherapy for canine mast cell tumours: 57 cases.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dog Diseases; Dogs; Female; Lomustine; Male | 2009 |
Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours.
Topics: Animals; Antineoplastic Agents; Benzamides; Blotting, Western; Calcitriol; Calcium Channel Agonists; | 2010 |